- /
- Supported exchanges
- / US
- / SION.NASDAQ
Sionna Therapeutics, Inc. Common Stock (SION NASDAQ) stock market data APIs
Sionna Therapeutics, Inc. Common Stock Financial Data Overview
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; and SION-719 and SION-451, which are nucleotide-binding domain 1 stabilizers in Phase 1 trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sionna Therapeutics, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sionna Therapeutics, Inc. Common Stock data using free add-ons & libraries
Get Sionna Therapeutics, Inc. Common Stock Fundamental Data
Sionna Therapeutics, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -82 841 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.6
Get Sionna Therapeutics, Inc. Common Stock End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sionna Therapeutics, Inc. Common Stock News
New
Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says
Sionna Therapeutics' (SION) valuation topping $2 billion is "too optimistic" as the company's early- PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Stocks Retreat as Bond Yields Rise
The S&P 500 Index ($SPX) (SPY) on Monday closed down by -0.53%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down by -0.90%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.36%. ...
Stocks Retreat as Bond Yields Rise
The S&P 500 Index ($SPX) (SPY) on Monday closed down by -0.53%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down by -0.90%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.36%. ...
Stocks Fall as Rising Bond Yields Spark Risk-Off Sentiment
The S&P 500 Index ($SPX) (SPY) today is down by -0.28%, the Dow Jones Industrials Index ($DOWI) (DIA) is down by -0.48%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down by -0.29%. December E-mini...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.